Literature DB >> 28025109

DEET potentiates the development and persistence of anticholinesterase dependent chronic pain signs in a rat model of Gulf War Illness pain.

L K Flunker1, T J Nutter2, R D Johnson3, B Y Cooper4.   

Abstract

Exposure to DEET (N,N-diethyl-meta-toluamide) may have influenced the pattern of symptoms observed in soldiers with GWI (Gulf War Illness; Haley and Kurt, 1997). We examined how the addition of DEET (400mg/kg; 50% topical) to an exposure protocol of permethrin (2.6mg/kg; topical), chlorpyrifos (CP; 120mg/kg), and pyridostigmine bromide (PB;13mg/kg) altered the emergence and pattern of pain signs in an animal model of GWI pain (Nutter et al., 2015). Rats underwent behavioral testing before, during and after a 4week exposure: 1) hindlimb pressure withdrawal threshold; 2) ambulation (movement distance and rate); and 3) resting duration. Additional studies were conducted to assess the influence of acute DEET (10-100μM) on muscle and vascular nociceptor Kv7, KDR, Nav1.8 and Nav1.9. We report that a 50% concentration of DEET enhanced the development and persistence of pain-signs. Rats exposed to all 4 compounds exhibited ambulation deficits that appeared 5-12weeks post-exposure and persisted through weeks 21-24. Rats exposed to only three agents (CP or PB excluded), did not fully develop ambulation deficits. When PB was excluded, rats also developed rest duration pain signs, in addition to ambulation deficits. There was no evidence that physiological doses of DEET acutely modified nociceptor Kv7, KDR, Nav1.8 or Nav1.9 activities. Nevertheless, DEET augmented protocols decreased the conductance of Kv7 expressed in vascular nociceptors harvested from chronically exposed rats. We concluded that DEET enhanced the development and persistence of pain behaviors, but the anticholinesterases CP and PB played a determinant role.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic Pain; DEET; Gulf War Illness; K(v)7; chlorpyrifos; pyridostigmine

Mesh:

Substances:

Year:  2016        PMID: 28025109     DOI: 10.1016/j.taap.2016.12.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Environmental Exposure History and Vulvodynia Risk: A Population-Based Study.

Authors:  Barbara D Reed; Kimberly S McKee; Melissa A Plegue; Sung Kyun Park; Hope K Haefner; Sioban D Harlow
Journal:  J Womens Health (Larchmt)       Date:  2018-10-10       Impact factor: 2.681

2.  Differential phosphoprotein signaling in the cortex in mouse models of Gulf War Illness using corticosterone and acetylcholinesterase inhibitors.

Authors:  Julia A Penatzer; Julie V Miller; Nicole Prince; Misa Shaw; Cayla Lynch; Mackenzie Newman; Gerald R Hobbs; Jonathan W Boyd
Journal:  Heliyon       Date:  2021-07-12

3.  Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness.

Authors:  Tanja Emmerich; Zuchra Zakirova; Nancy Klimas; Kimberly Sullivan; Ashok K Shetty; James E Evans; Ghania Ait-Ghezala; Gary S Laco; Bharathi Hattiangady; Geetha A Shetty; Michael Mullan; Gogce Crynen; Laila Abdullah; Fiona Crawford
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

4.  A role for neuroimmune signaling in a rat model of Gulf War Illness-related pain.

Authors:  Michael J Lacagnina; Jiahe Li; Sabina Lorca; Kenner C Rice; Kimberly Sullivan; James P O'Callaghan; Peter M Grace
Journal:  Brain Behav Immun       Date:  2020-10-27       Impact factor: 7.217

Review 5.  Acetylcholinesterase inhibitor exposures as an initiating factor in the development of Gulf War Illness, a chronic neuroimmune disorder in deployed veterans.

Authors:  Lindsay T Michalovicz; Kimberly A Kelly; Kimberly Sullivan; James P O'Callaghan
Journal:  Neuropharmacology       Date:  2020-04-02       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.